Table 7.
[18F]PSMA-1007 PET/CT in 78 patients initially treated with radical prostatectomy (F-RP): subgroups of patients according to the number of PSMA-positive lesions categorized by pre-scan PSA threshold 1.08 ng/mL.
| PSA Range (ng/mL) |
Overall
Positivity |
p/r-Value | Oligo-Metastatic | Multi-Metastatic | p/r-Value | |
| <1.08 (38) | 29 (76.3%) | 12 (31.6%) | 11 (28.9%) | |||
| ≥1.08 (40) | 40 (100%) | 8 (20.0%) | 27 (67.5%) | |||
| Total (78) | 69 (88.4%) |
p = 0.001 r = 0.371 |
20 (25.6%) | 38 (48.7%) |
p = 0.002 r = 0.394 |
|
| PSA Range (ng/mL) |
Local
Recurrence |
p/r-Value | Local Metastases |
Distant
Metastases |
Local + Distant Metastases | p/r-Value |
| <1.08 (38) | 11 (28.9%) | 22 (57.9%) | 1 (2.6%) | 0 (0%) | ||
| ≥1.08 (40) | 17 (42.5%) | 20 (50.0%) | 13 (32.5%) | 2 (5.0%) | ||
| Total (78) | 28 (35.9%) |
p = 0.212 r = 0.141 |
42 (53.8%) | 14 (17.9%) | 2 (2.6%) |
p < 0.001 r = 0.456 |
Abbreviations: PSA, prostate-specific antigen; p-value < 0.05 is considered significant.